Dear all,
Welcome to week three of our discussion on Open Access, and a huge thank you to everyone who has shared their experiences so far! To contribute, please send an email to: hifa@hifaforums.org You can review past messages on our RSS feed here: https://www.hifa.org/rss-feeds/17
Here again is our landing page for further information: https://www.hifa.org/news/hifa-announces-deep-dive-discussion-healthcare...
This week (28 October - 2 November) we are looking at Q3: What is your experience of OA as a researcher/author?
Last week we explored healthcare professional's experiences of OA as readers of medical publications. This week, we focus on OA from the perspective of healthcare professionals as researchers and authors of medical publications.
To address this knowledge gap, we are keen to explore the following factors:
- How often do healthcare professional's participate as authors on research articles?
- Do healthcare professionals consider OA publishing as a driving factor when selecting journals?
- How would you rate healthcare professionals understanding of Creative Commons licences?
We are especially interested to hear actual practical examples and observations. For example, can you describe a situation where a healthcare professional made a conscious decision to publish with or without OA, including the reasons behind the decision?
Please do feel free to comment on any aspect of open access that you feel is relevant to this discussion.
As a reminder, the HIFA Open Access working group proposes the following guiding questions:
1. What is the impact of open access (OA) on health care?
2. What is your experience of OA as a healthcare professional/reader? (last week)
3. What is your experience of OA as a researcher/author? (this week)
4. How would you design an OA system that retains the benefits but fixes the problems of the current OA system? (next week)
5. Open discussion and next steps.
We look forward to your contributions: hifa@hifaforums.org
Many thanks, Joanna
Joanna Donnelly PhD
Communications Consultant
Oxford PharmaGenesis Ltd
UK Tel: +44 1865 390144
joanna.donnelly@pharmagenesis.com
www.pharmagenesis.com
Oxford PharmaGenesis Ltd is registered in England and Wales, registration number 03488862. Our registered office is at Tubney Warren Barn, Tubney, Oxford, OX13 5QJ, UK.
HIFA profile: Joanna Donnelly DPhil is a Communications Consultant at Oxford PharmaGenesis and leads the open access working group and AI discussion forum at Open Pharma, a multi-sponsor collaboration facilitated by Oxford PharmaGenesis seeking to drive transparency in the communication of pharma-sponsored research. She is a member of the HIFA Open Access working group. https://www.hifa.org/support/members/joanna